Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line

Journal of Neuro-Oncology

Volumn 102, Issue 2, 2011, Pages 237-245

  Lv, Hongtao ^a   Li, Chuzhong ^a   Gui, Songbai ^b   Sun, Meizhen ^a   Li, Dan ^a   Zhang, Yazhuo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen receptor ; Fulvestrant; Growth factor; MMQ; Prolactinoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GROWTH FACTOR; PROLACTIN; SECURIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MMQ; CONTROLLED STUDY; NONHUMAN; PROLACTIN RELEASE; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 79953717734     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0326-2     Document Type: Article

References (34)

1. Yin P, Arita J (2000) Differential regulation of prolactin release and lactotrope proliferation during pregnancy, lactation and the estrous cycle. Neuroendocrinology 72:72-79
2. Lloyd RV (1983) Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 113:198-206
3. Molitch ME (1999) Management of prolactinomas during pregnancy. J Reprod Med 44(12 Suppl):1121-1126
4. Carol W, Lauterbach H, Klinger G, Unger A, Michels W (1988) Prolactin stimulation using the metoclopramide test in females taking oral contraceptives. Zentralbl Gynakol 110:1515-1521 (in German)
5. Shy KK, McTiernan AM, Daling JR, Weiss NS (1983) Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 249:2204-2207 (Pubitemid 13118678)
6. Elias KA, Weiner RI (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci U S A 81:4549-4553 (Pubitemid 14055929)
7. Raymond V, Beaulieu M, Labrie F, Boissier J (1978) Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200:1173-1175 (Pubitemid 9087509)
8. Sarkar Dk, Hentges ST, De A, Reddy RH (1998) Hormonal control of pituitary prolactin-secreting tumors. Front Biosci 3:d934-d943
9. Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53 (Pubitemid 26268330)
10. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS (1994) Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269:4458-4466
11. Aronica SM, Katzenellenbogen BS (1991) Progestrone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′,5′- monophosphate, and insulin-like growth factor I and supression by antiestrogens and protein kinase inhibitors. Endocrinology 128:2045-2052
12. Beck CA, Weigel NL, Edwards DP (1992) Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol 6:607-620
13. Sirbasku DA (1978) Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary and kidney tumor cells. Proc Natl Acad Sci U S A 75:3786-3790
14. Soto AM, Sonnenschein C (1987) Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev 8:44-52
15. Judd AM, Login IS, Kovacs K, Ross PC, Spangelo BL, Jarvis WD, MacLeod RM (1988) Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine. Endocrinology 123:2341-2350
16. Wakeling AE, Dukes M, Bowler J (1991) A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873
17. Lykkesfeldt AE, Madsen MW, Briand P (1994) Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164, 384 and ICI 182, 780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Cancer Res 54:1587-1595
18. Gottardis MM, Jiang SY, Jeng MH, Jordan VC (1989) Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens. Cancer Res 49:4090-4093 (Pubitemid 19207240)
19. Bross PF, Baird A, Chen G, Jee JM, Lostritto RT, Morse DE, Rosario LA, Williams GM, Yang P, Rahman A, Williams G, Pazdur R (2003) Fulvestrant in postmenopausal women with advanced breast cancer. Clin Cancer Res 9:4309-4317 (Pubitemid 37248385)
20. Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG (1990) Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164, 384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A 87:6883-6887
21. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA (1993) Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998 (Pubitemid 23252338)
22. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A 96:4686-4691 (Pubitemid 29190397)
23. Cenni B, Picard D (1999) Ligand-independent activation of steroid receptors: new roles for old players. Trends Endocrinol Metab 10:41-46 (Pubitemid 29287821)
24. El-Tanani MK, Green CD (1997) Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol Endocrinol 11:928-937 (Pubitemid 27241785)
25. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S (2000) Pituitary-tumour transforming gene in colorectal tumors. Lancet 355:712-715
26. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317-1321 (Pubitemid 29535612)
27. Amano O, Yoshitake Y, Nishikawa K, Iseki S (1993) Immunocytochemical localization of basic fibroblast growth factor in the rat pituitary gland. Arch Histol Cytol 56:269-276 (Pubitemid 23329606)
28. Elias KA, Weiner RI (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci U S A 81:4549-4553 (Pubitemid 14055929)
29. Chaturvedi K, Sarkar DK (2004) Involvement of protein kinase C-dependent mitogen-activated protein kinase p44/42 signaling pathway for cross-talk between estradiol and transforming growth factor-beta3 in increasing basic fibroblast growth factor in folliculostellate cells. Endocrinology 145:706-715 (Pubitemid 38183814)
30. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK (1995) Reduction in the expression and action of transforming growth factor β1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res 55:4892-4898
31. Minami S, Sarkar DK (1997) Transforming growth factor-β1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of estrogen-treated Fischer 344 rats. Neurochem Int 30:499-506
32. Hentges S, Boyadjieva N, Sarkar DK (2000) Transforming growth factor-β3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141:859-867 (Pubitemid 32260428)
33. Brattain MG, Markowitz SD, Willson JKV (1996) The type II transforming growth factor-βreceptor as a tumor-suppressor gene. Curr Opin Oncol 8:49-53 (Pubitemid 26092845)
34. Sarkar DK, Pastorcic M, De A, Engel M, Moses H, Ghasemzadeh B (1998) Role of transforming growth factor (TGF)-βtype I and TGF-β type II receptors in the TGF-β1-regulated gene expression in pituitary prolactin-secreting lactotropes. Endocrinology 139:3620-3628 (Pubitemid 28512322)